Found: 27
Select item for more details and to access through your institution.
Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis.
- Published in:
- GeroScience, 2022, v. 44, n. 3, p. 1727, doi. 10.1007/s11357-022-00565-9
- By:
- Publication type:
- Article
Correction to: Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Selective Heart Irradiation Induces Cardiac Overexpression of the Pro-hypertrophic miR-212.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00598
- By:
- Publication type:
- Article
Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-37690-5
- By:
- Publication type:
- Article
Porcine model of progressive cardiac hypertrophy and fibrosis with secondary postcapillary pulmonary hypertension.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Δ<sup>8</sup>-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB<sub>2</sub> receptors.
- Published in:
- British Journal of Pharmacology, 2012, v. 165, n. 8, p. 2450, doi. 10.1111/j.1476-5381.2011.01410.x
- By:
- Publication type:
- Article
A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury.
- Published in:
- 2012
- By:
- Publication type:
- journal article
A new cannabinoid CB<sub>2</sub> receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury.
- Published in:
- British Journal of Pharmacology, 2012, v. 165, n. 8, p. 2462, doi. 10.1111/j.1476-5381.2011.01381.x
- By:
- Publication type:
- Article
Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy.
- Published in:
- Diabetes, 2012, v. 61, n. 3, p. 716, doi. 10.2337/db11-0477
- By:
- Publication type:
- Article
MicroRNAs in Hypertension: Mechanisms and Therapeutic Targets.
- Published in:
- Current Hypertension Reports, 2012, v. 14, n. 1, p. 79, doi. 10.1007/s11906-011-0235-6
- By:
- Publication type:
- Article
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity.
- Published in:
- 2010
- By:
- Publication type:
- journal article
CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model.
- Published in:
- 2010
- By:
- Publication type:
- journal article
CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.
- Published in:
- Cardiovascular Research, 2010, v. 85, n. 4, p. 773, doi. 10.1093/cvr/cvp369
- By:
- Publication type:
- Article
Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy.
- Published in:
- Journal of Cellular & Molecular Medicine, 2009, v. 13, n. 8b, p. 2330, doi. 10.1111/j.1582-4934.2008.00564.x
- By:
- Publication type:
- Article
CB<sub>2</sub> Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis.
- Published in:
- PLoS ONE, 2009, v. 4, n. 7, p. 1, doi. 10.1371/journal.pone.0006409
- By:
- Publication type:
- Article
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Peripheral Endocannabinoid System Activity in Patients Treated With Sibutramine.
- Published in:
- Obesity (19307381), 2008, v. 16, n. 5, p. 1135, doi. 10.1038/oby.2008.47
- By:
- Publication type:
- Article
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury.
- Published in:
- FASEB Journal, 2007, v. 21, n. 8, p. 1788, doi. 10.1096/fj.06-7451com
- By:
- Publication type:
- Article
Dysregulation of the Peripheral and Adipose Tissue Endocannabinoid System in Human Abdominal Obesity.
- Published in:
- Diabetes, 2006, v. 55, n. 11, p. 3053, doi. 10.2337/db06-0812
- By:
- Publication type:
- Article
Cannabinoids hurt, heal in cirrhosis.
- Published in:
- Nature Medicine, 2006, v. 12, n. 6, p. 608, doi. 10.1038/nm0606-608
- By:
- Publication type:
- Article
Cirrhotic cardiomyopathy: an endocannabinoid connection?
- Published in:
- 2005
- By:
- Publication type:
- journal article
Activation of the peripheral endocannabinoid system in human obesity.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Haemodynamic profile and responsiveness to anandamide of TRPV<sub>1</sub> receptor knock-out mice.
- Published in:
- Journal of Physiology, 2004, v. 558, n. 2, p. 647, doi. 10.1113/jphysiol.2004.064824
- By:
- Publication type:
- Article
Endocannabinoids acting at vascular CB<sub>1</sub> receptors mediate the vasodilated state in advanced liver cirrhosis.
- Published in:
- Nature Medicine, 2001, v. 7, n. 7, p. 827
- By:
- Publication type:
- Article
Ischemia/reperfusion-induced changes in intracellular free Ca<sup>2+</sup> levels in rat skeletal muscle fibers – an in vivo study.
- Published in:
- Pflügers Archiv: European Journal of Physiology, 2000, v. 440, n. 2, p. 302, doi. 10.1007/s004240000287
- By:
- Publication type:
- Article